NCT03758651View on ClinicalTrials.gov

Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study

CompletedOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

November 30, 2022

Study Completion Date

September 14, 2023

Conditions
Williams SyndromeLipedema
Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Williams Syndrome Association

UNKNOWN

lead

Massachusetts General Hospital

OTHER

NCT03758651 - Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study | Biotech Hunter | Biotech Hunter